Genesco Reports Strong Holiday Sales, Raises Fiscal 2026 Adjusted EPS Guidance
GCO has more than doubled off its 52-week low of $16.19 on elevated volume (2.7× avg).
Summary
Genesco Inc. announced a 9% increase in comparable sales for the fourth fiscal quarter-to-date period, driven by strong holiday performance, and subsequently raised its fiscal 2026 adjusted EPS guidance to at least $1.30 per share.
Key Events · Earnings and Guidance · GCO
-
Strong Holiday Sales Growth
Comparable sales increased 9% for the quarter-to-date period ended December 27, 2025, with same-store sales up 10% and e-commerce up 9%.
-
Journeys Group Outperforms
The Journeys Group achieved a 12% comparable sales increase, reflecting strong conversion and full-price selling during the holiday season.
-
Raised EPS Guidance
The company now expects fiscal 2026 adjusted earnings per share to be at least $1.30, a meaningful improvement from its most recent outlook.
-
ICR Conference Presentation
Management will present at the 2026 ICR Conference on January 12, 2026, to provide further business updates.
Analysis · GCO · Trade & Services
The positive comparable sales growth, particularly the double-digit increase at Journeys, indicates strong consumer demand and effective execution during the critical holiday shopping season. The upward revision of full-year adjusted EPS guidance signals improved profitability expectations, despite some margin pressure at Schuh. This update provides a positive outlook for the company's financial performance.
How filings like this one have moved
In the 30 days to Sep 12, 2026, 35.5% of the 1531 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.19%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, GCO was trading at $33.00 on NYSE in the Trade & Services sector, with a market capitalization of approximately $315M. The 52-week trading range was $16.19 to $43.81. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.